Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Efficacy and Safety of Curcumin Formulation in Alzheimer's DiseaseCurcumin is shown to impact several different pathways of neuroprotection, however clinical trials have not shown positive results, due to the poor bioavailability of curcumin. This study is designed to determine efficacy and safety of high-bioavailability curcumin formulation (Longvida) in subjects with Alzheimer's disease. Alzheimer Non applicable Neuroprotection India À vérifier
Efficacy and Safety of Curcumin Formulation in Alzheimer's DiseaseCurcumin is shown to impact several different pathways of neuroprotection, however clinical trials have not shown positive results, due to the poor bioavailability of curcumin. This study is designed to determine efficacy and safety of high-bioavailability curcumin formulation (Longvida) in subjects with Alzheimer's disease. Alzheimer Non applicable Neuroprotection India À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease Alzheimer Non applicable NCT01001637 Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease TERMINATED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.